The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Resilience and reduced c-Fos expression in P2X7 receptor knockout mice exposed to repeated forced swim test
Abstract
There is considerable evidence suggesting genetic factors play an important role in the pathophysiology of depression, possibly by increasing susceptibility to repeated environmental stressors. Recent linkage studies have associated a polymorphism of the gene coding for the P2X7 receptor (P2X7R) with both major depressive disorder and bipolar disorder. Here we assessed whether P2X7 deletion affected the behavioural and neural response to repeated stress. P2X7R knockout (P2X7-/-) mice were subjected to the forced swim test for three consecutive days and neuronal activation in response to the third exposure was assessed using c-Fos immunohistochemistry. In addition, anxiety was evaluated in another group of P2X7-/- mice using the elevated plus maze (EPM) and light dark emergence (LDE) tests. Equivalent levels of immobility were observed in P2X7-/- mice and wild-type (WT) mice on the first exposure to forced swim, but much greater immobility was seen in WT mice on second and third exposures. This suggests that P2X7-/- mice exhibit an impaired adaptive coping response to repeated stress. Reinforcing this view, c-Fos expression in the dentate gyrus of the hippocampus and in the basolateral amygdala was seen in WT mice but not P2X7-/- mice following repeated forced swim. In addition, decreased locomotor activity was detected in P2X7-/- mice without any specific effects on anxiety in the LDE test. However, P2X7-/- mice showed greater anxiety-like behaviour in the EPM. These data suggest that the P2X7R may be involved in the adaptive mechanisms elicited by exposure to repeated environmental stressors that leads to the development of depression-like behaviours. This suggests that P2X7R antagonists may be useful therapeutics for the treatment of major depression, possibly by increasing resilience in the face of repeated stress.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In another study, however, the changed behavioral phenotype of P2X7R KO mice was only observed when mice were repeatedly exposed to the FST, indicating that absence of P2X7R-mediated signaling can facilitate behavioral adaptation upon repeated stress exposure, preventing development of depressive-like behaviors, following a single exposure to the stressful condition [86].”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [86]
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
Genetic Epidemiology of Major Depression: Review and Meta-Analysis
Sullivan, P. F., Neale, M. C., & Kendler, K. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1552 · Cited by 3,431
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,320
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
The use of a plus-maze to measure anxiety in the mouse
Lister, R. G. (1987) · Psychopharmacology · doi:10.1007/bf00177912 · Cited by 2,617
Causal Relationship Between Stressful Life Events and the Onset of Major Depression
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.837 · Cited by 2,566 · cited 3×
“While there is a high degree of heritability in depression, and it is well recognized that stressful life events significantly increase the onset of depression (Kendler et al., 1999), none of those factors alone can inevitably predict the likelihood of developing the disorder (Kas et al., in press).”
BackgroundInfluentialMcEwen, B. S. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02950-4 · Cited by 1,827
Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines
Crawley, J. N., & Goodwin, F. K. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90067-2 · Cited by 1,432
The habenula: from stress evasion to value-based decision-making
Hikosaka, O. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2866 · Cited by 955
Altered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J. M., Perregaux, D. G., Stam, E. J., Petrushova, N., Koller, B. H., Griffiths, R., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 924
Cited by
Sorted by citations
The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses
Iwata, M., Ota, K. T., & Duman, R. S. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.12.008 · Cited by 580
The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
Savio, L. E. B., de Andrade Mello, P., da Silva, C. G., & Coutinho-Silva, R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00052 · Cited by 437
Purinergic signalling: From normal behaviour to pathological brain function
Burnstock, G., Krügel, U., Abbracchio, M. P., & Illés, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.006 · Cited by 402
The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
Bartlett, R., Stokes, L., & Sluyter, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008003 · Cited by 409
P2X7 receptor: an emerging target in central nervous system diseases
Sperlágh, B., & Illes, P. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.08.002 · Cited by 390
Iwata, M., Ota, K. T., Li, X.-Y., Sakaue, F., Li, N., Dutheil, S., Banasr, M., Duric, V., Yamanashi, T., Kaneko, K., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.026 · Cited by 387
Yue, N., Huang, H., Zhu, X., Han, Q., Wang, Y., Li, B., Liu, Q., Wu, G., Zhang, Y., & Yu, J. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0865-y · Cited by 334
P2X7 Receptors: Channels, Pores and More
Volonté, C., Apolloni, S., Skaper, S. D., & Burnstock, G. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712803581137 · Cited by 259
Molecular and functional properties of P2X receptors—recent progress and persisting challenges
Kaczmarek-Hájek, K., Lörinczi, É., Hausmann, R., & Nicke, A. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9314-7 · Cited by 237
The microglial ATP‐gated ion channel P2X7 as a CNS drug target
Bhattacharya, A., & Biber, K. (2016) · Glia · doi:10.1002/glia.23001 · Cited by 221
Bhattacharya, A., Wang, Q., Ao, H., Shoblock, J. R., Lord, B., Aluisio, L. E., Fraser, I. C., Nepomuceno, D. H., Neff, R. A., Welty, N., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12314 · Cited by 204
The P2X7 Receptor: Central Hub of Brain Diseases
Andrejew, R., Oliveira-Giacomelli, Á., Ribeiro, D. E., Glaser, T., Arnaud-Sampaio, V. F., Lameu, C., & Ulrich, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00124 · Cited by 162
Ullrich (2018) · doi:10.1038/mp.2017.188 · Cited by 145
Role of neuro-immunological factors in the pathophysiology of mood disorders
Bhattacharya, A., Derecki, N. C., Lovenberg, T. W., & Drevets, W. C. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4214-0 · Cited by 149
The First CNS-Active Carborane: A Novel P2X7 Receptor Antagonist with Antidepressant Activity
Wilkinson, S. M., Gunosewoyo, H., Barron, M. L., Boucher, A. A., McDonnell, M., Turner, P., Morrison, D. E., Bennett, M. R., McGregor, I. S., Rendina, L. M., et al. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500054n · Cited by 143
Tan, S., Wang, Y., Chen, K., Long, Z., & Zou, J. (2017) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00131 · Cited by 142
P2X7 Receptor Signaling in Stress and Depression
Ribeiro, D. E., Roncalho, A. L., Glaser, T., Ulrich, H., Wegener, G., & Joca, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112778 · Cited by 129
Csölle, C., Baranyi, M., Zsilla, G., Kittel, Á., Gölöncsér, F., Illes, P., Papp, E., Vizi, E. S., & Sperlágh, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066547 · Cited by 128
Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics
Ortiz, R., Ulrich, H., Zarate, C. A., & Machado‐Vieira, R. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.10.016 · Cited by 129
Recent advances in CNS P2X7 physiology and pharmacology: Focus on neuropsychiatric disorders
Bhattacharya, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00030 · Cited by 115
Central nervous system myeloid cells as drug targets: current status and translational challenges
Biber, K. P. H., Möller, T., Boddeke, E., & Prinz, M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.14 · Cited by 111
Csölle, C., Andó, R. D., Kittel, Á., Gölöncsér, F., Baranyi, M., Soproni, K., Zelena, D., Haller, J., Németh, T., Mócsai, A., et al. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001933 · Cited by 108
“These observations confirm and extend previous data, which showed decreased immobility in the TST (Basso et al. 2009) and decreased floating time in the FST on the second day (Boucher et al. 2011) after genetic deletion.”
BackgroundMethodResultInfluentialPurinergic mechanisms in neuroinflammation: An update from molecules to behavior
Beamer, E. H., Gölöncsér, F., Horváth, G., Bekő, K., Otrokocsi, L., Koványi, B., & Sperlágh, B. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.019 · Cited by 114
Faster, better, stronger: Towards new antidepressant therapeutic strategies
O’Leary, O. F., Dinan, T. G., & Cryan, J. F. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.046 · Cited by 104
P2X7 Receptor: A Potential Therapeutic Target for Depression?
Deussing, J. M., & Arzt, E. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.07.005 · Cited by 97
Purinergic receptors in psychiatric disorders
Krügel, U. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.032 · Cited by 96
Su, W.-J., Zhang, T., Jiang, C.-L., & Wang, W. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00412 · Cited by 84
Farooq, R. K., Tanti, A., Ainouche, S., Roger, S., Belzung, C., & Camus, V. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.07.016 · Cited by 83
Bhattacharya, A., Lord, B., Grigoleit, J., He, Y., Fraser, I. C., Campbell, S. N., Taylor, N., Aluisio, L. E., O’Connor, J. C., Papp, M., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0141-6 · Cited by 84
Pathological ATPergic Signaling in Major Depression and Bipolar Disorder
Illés, P., Verkhratsky, A., & Tang, Y. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00331 · Cited by 78
Rahimian, R., Belliveau, C., Chen, R., & Mechawar, N. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.871997 · Cited by 77
Astrocytes and major depression: The purinergic avenue
Zhao, Y. F., Verkhratsky, A., Tang, Y. C., & Illés, P. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109252 · Cited by 76
Recourt, K., de Boer, P., van der Ark, P. D., Beneš, H., van Gerven, J., Ceusters, M., Nueten, L. V., Drevets, W. C., Bhatacharya, A., Browning, M. D., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02557-5 · Cited by 72
Timmers, M., Ravenstijn, P. G. M., Xi, L., Triana‐Baltzer, G., Furey, M., Hemelryck, S. V., Biewenga, J., Ceusters, M., Bhattacharya, A., van den Boer, M., et al. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118800067 · Cited by 69
P2X7 Antagonists as Potential Therapeutic Agents for the Treatment of CNS Disorders
Chrovian, C. C., Rech, J. C., Bhattacharya, A., & Letavic, M. A. (2014) · Progress in medicinal chemistry · doi:10.1016/b978-0-444-63380-4.00002-0 · Cited by 69
Pereira, V. S., Casarotto, P. C., Hiroaki-Sato, V. A., Sartim, A. G., Guimarães, F. S., & Joca, S. R. L. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.01.008 · Cited by 66
Rimmerman, N., Schottlender, N., Reshef, R., Dan-Goor, N., & Yirmiya, R. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.11.023 · Cited by 66
Purinergic Signaling and Related Biomarkers in Depression
Bartoli, F., Burnstock, G., Crocamo, C., & Carrà, G. (2020) · Brain Sciences · doi:10.3390/brainsci10030160 · Cited by 64
Sebastián‐Serrano, Á., Engel, T., de Diego-García, L., Olivos-Oré, L. A., Arribas-Blázquez, M., Martínez-Frailes, C., Pérez-Díaz, C., Millán, J. L., Artalejo, A. R., Miras‐Portugal, M. T., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw248 · Cited by 63
Recourt, K., van der Aart, J., Jacobs, G. E., de Kam, M., Drevets, W. C., Nueten, L. V., Kanhai, K. M. S., Siebenga, P. S., Zuiker, R. G. J. A., Ravenstijn, P. G. M., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120914206 · Cited by 61
Metzger, M. W., Walser, S. M., Dedic, N., Aprile-Garcia, F., Jakubcakova, V., Adamczyk, M., Webb, K. J., Uhr, M., Refojo, D., Schmidt, M. V., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3487-16.2017 · Cited by 59
Purinergic Signaling and Energy Homeostasis in Psychiatric Disorders
Lindberg, D. M., Shan, D., Ayers-Ringler, J. R., Oliveros, A., Benitez, J. C. A., Prieto, M. L., McCullumsmith, R. E., & Choi, D. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150330163724 · Cited by 65
Understanding the role of P2X7 in affective disorders—are glial cells the major players?
Stokes, L., Spencer, S. J., & Jenkins, T. A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00258 · Cited by 59
A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334
Lord, B., Ameriks, M. K., Wang, Q., Fourgeaud, L., Vliegen, M., Verluyten, W. L. M., Haspeslagh, P., Carruthers, N. I., Lovenberg, T. W., Bonaventure, P., et al. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.09.026 · Cited by 55
Ma, M., Ren, Q., Zhang, J.-C., & Hashimoto, K. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.1.31 · Cited by 55
P2X7 Receptors Mediate Innate Phagocytosis by Human Neural Precursor Cells and Neuroblasts
Lovelace, M. D., Gu, B. J., Eamegdool, S. S., Weible, M. W., Wiley, J. S., Allen, D. G., & Chan‐Ling, T. (2014) · Stem Cells · doi:10.1002/stem.1864 · Cited by 51
P2X7 Receptors Drive Spine Synapse Plasticity in the Learned Helplessness Model of Depression
Otrokocsi, L., Kittel, Á., & Sperlágh, B. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx046 · Cited by 52
maLPA1-null mice as an endophenotype of anxious depression
Moreno‐Fernández, R. D., Pérez‐Martín, M., Castilla‐Ortega, E., Rosell‐Valle, C., Garcia‐Fernandez, M. I., Chun, J. J. M., Estivill‐Torrús, G., de Fonseca, F. R., Santín, L. J., & Pedraza, C. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.24 · Cited by 48
Gürsel (2018) · doi:10.1016/j.neubiorev.2018.02.005 · Cited by 47
Ribeiro, D. E., Müller, H. K., Elfving, B., Eskelund, A., Joca, S. R., & Wegener, G. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119872173 · Cited by 45
P2X7R antagonists in chronic stress-based depression models: a review
von Mücke-Heim, I.-A., Ries, C., Urbina-Treviño, L., & Deussing, J. M. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01306-3 · Cited by 47
Chen, Y., Lin, S., Jin, S., & Gao, T. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.04.013 · Cited by 42
Zhao, Y.-F., Ren, W.-J., Zhang, Y., He, J., Yin, H., Liao, Y., Rubini, P., Deussing, J. M., Verkhratsky, A., Yuan, Z., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031904 · Cited by 41
O’Brien-Brown, J., Jackson, A. R., Reekie, T. A., Barron, M. L., Werry, E. L., Schiavini, P., McDonnell, M., Munoz, L., Wilkinson, S. M., Noll, B. D., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.02.060 · Cited by 37
Association of purinergic receptor P2RX7 gene polymorphisms with depression symptoms
Vereczkei, A., Abdul-Rahman, O., Halmai, Z., Nagy, G., Székely, A., Somogyi, A., Faludi, G., & Nemoda, Z. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.01.006 · Cited by 37
Brain immune cells characterization in UCMS exposed P2X7 knock-out mouse
Troubat, R., Leman, S., Pinchaud, K., Surget, A., Barone, P. R., Roger, S., Guisquet, A. L., Brizard, B., Belzung, C., & Camus, V. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.02.012 · Cited by 34
Li, Y., Dang, X., Chen, R., Teng, Z., Wang, J., Li, S., Yue, Y., Mitchell, B. L., Zeng, Y., Yao, Y.-G., et al. (2025) · Nature Human Behaviour · doi:10.1038/s41562-024-02073-6 · Cited by 30
Furuyashiki, T. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12r09cp · Cited by 29
Kongsui, R., Beynon, S. B., Johnson, S. J., Mayhew, J., Kuter, P., Nilsson, M., & Walker, F. R. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.05.017 · Cited by 29
Brzozowska, N., Smith, K. L., Zhou, C., Waters, P. M., Cavalcante, L. M., Abelev, S. V., Kuligowski, M., Clarke, D. J., Todd, S. M., & Arnold, J. C. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.05.008 · Cited by 28
Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor
Gil, B., Smith, J., Tang, Y., Illés, P., & Engel, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042380 · Cited by 27
Monoamine involvement in the antidepressant-like effect induced by P2 blockade
Diniz, C. R. A. F., Rodrigues, M., Casarotto, P. C., Pereira, V. S., Crestani, C. C., & Joca, S. R. L. (2017) · Brain Research · doi:10.1016/j.brainres.2017.09.011 · Cited by 25
Purinergic transmission in depressive disorders
Szopa, A., Socała, K., Serefko, A., Doboszewska, U., Wróbel, A., Poleszak, E., & Właź, P. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107821 · Cited by 25
Domingos, L. B., Hott, S. C., Terzian, A. L. B., & Resstel, L. B. M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.005 · Cited by 25
P2X7 receptor-mediated depression-like reactions arising in the mouse medial prefrontal cortex
Ren, W., Zhao, Y.-F., Li, J., Rubini, P., Yuan, Z., Tang, Y., & Illés, P. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad166 · Cited by 24
Campos, R. C., Parfitt, G. M., Polese, C. E., Coutinho‐Silva, R., Morrone, F. B., & Barros, D. M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.017 · Cited by 22
Ribeiro, D. E., Casarotto, P. C., Staquini, L., Pinto e Silva, M. A., Biojone, C., Wegener, G., & Joca, S. (2019) · PeerJ · doi:10.7717/peerj.7834 · Cited by 21
P2X7 Receptor as a Potential Target for Major Depressive Disorder
Huang, Z., & Tan, S. (2021) · Current Drug Targets · doi:10.2174/1389450122666210120141908 · Cited by 20
P2X7 Receptor-Related Genetic Mouse Models – Tools for Translational Research in Psychiatry
Urbina-Treviño, L., von Mücke-Heim, I.-A., & Deussing, J. M. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2022.876304 · Cited by 23
Moreno‐Fernández, R. D., Nieto-Quero, A., Gómez-Salas, F. J., Chun, J. J. M., Estivill‐Torrús, G., de Fonseca, F. R., Santín, L. J., Pérez‐Martín, M., & Pedraza, C. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035519 · Cited by 22
Tang, Y., Illes, P., Zhang, Y., Yin, H.-Y., & Rubini, P. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220302152400 · Cited by 20
Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease
Ribeiro, D. E., Petiz, L. L., Glaser, T., Oliveira‐Giacomelli, Á., Andrejew, R., Saab, F. D. A. R., Milanis, M. D. S., Campos, H. C., Arnaud-Sampaio, V. F., de Oliveira, S. L. B., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109371 · Cited by 21
Akçay, E., & Karataş, H. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100853 · Cited by 18
Wu, H., Cottingham, C., Chen, L., Wang, H., Che, P., Liu, K., & Wang, Q. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180638 · Cited by 16
HCN channels in the hippocampus regulate active coping behavior
Fisher, D. W., Han, Y. S., Lyman, K. A., Heuermann, R. J., Bean, L. A., Ybarra, N., Foote, K. M., Dong, H., Nicholson, D. A., & Chetkovich, D. M. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14539 · Cited by 16
Gonzales, E. L., Jeon, S. J., Han, K., Yang, S. J., Kim, Y., Remonde, C. G., Ahn, T. J., Ham, B., & Shin, C. Y. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.06.017 · Cited by 14
The effects of P2X7 receptor knockout on emotional conditions over the lifespan of mice
Gao, L., Lin, Z., Xie, G., Zhou, T. G., Hu, W., Liu, C., Liu, X., Wang, X., Qian, M., & Ni, B. (2018) · Neuroreport · doi:10.1097/wnr.0000000000001136 · Cited by 13
Spencer, J. R., Darbyshire, K. M. E., Boucher, A. A., & Arnold, J. C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.014 · Cited by 10
Moreno‐Fernández, R. D., Sampedro‐Piquero, P., Gómez-Salas, F. J., Nieto-Quero, A., Estivill‐Torrús, G., de Fonseca, F. R., Santín, L. J., & Pedraza, C. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114681 · Cited by 10
Majkutewicz, I., Myślińska, D., Jerzemowska, G., Plucińska, K., Listowska, M., Grembecka, B., Podlacha, M., & Wrona, D. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.06.011 · Cited by 9
Glial Purinergic Signaling‐Mediated Oxidative Stress (GPOS) in Neuropsychiatric Disorders
Huang, L., Tang, Y., & Sperlágh, B. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1075440 · Cited by 9
Nrg1 deficiency modulates the behavioural effects of prenatal stress in mice
Clarke, D. J., Sarkissian, L. L., Todd, S. M., Suraev, A. S., Bahceci, D., Brzozowska, N., & Arnold, J. C. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.06.013 · Cited by 8
Smith, K. L., Todd, S. M., Boucher, A. A., Bennett, M. R., & Arnold, J. C. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134575 · Cited by 7
Kong, Y., Wang, Q., Wu, D., Hu, J., Zang, W., Li, X., Yang, J., & Gao, T. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12691 · Cited by 7
de Diego-García, L., Ramirez-Escudero, M., Sebastián‐Serrano, Á., Díaz‐Hernandéz, J. I., Pintor, J. J., Lucas, J. J., & Dı́az-Hernández, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.10.012 · Cited by 6
Razavi, Y., Karimi, S., Karimi‐Haghighi, S., Hesam, S., & Haghparast, A. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0712 · Cited by 5
P2X7 in Bipolar and Depressive Disorders
Barron, M. L., Werry, E. L., McGregor, I. S., & Kassiou, M. (2013) · Springer eBooks · doi:10.1007/978-3-642-40282-1_31 · Cited by 5
Emerging neurobiological targets in psychiatric treatment
Zoysa, A. I. D., Govinnage, J., Giorlando, F., Dodd, S., Narayanaswamy, J., & Berk, M. (2026) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2026.112767 · Cited by 4
von Mücke-Heim, I.-A., Oldekamp, J., Metzger, M. W., Kläffgen, S., Tang, H., Walser, S. M., Dedic, N., Rammes, G., Holsboer, F., Wurst, W., et al. (2025) · Purinergic Signalling · doi:10.1007/s11302-025-10074-x · Cited by 4
Kristóf, Z., Szabó, D., Sperlágh, B., Török, D., & Gonda, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104687 · Cited by 5
Freeman, A. R., Hare, J. F., & Caldwell, H. K. (2020) · Brain and Behavior · doi:10.1002/brb3.1629 · Cited by 4
Myślińska, D., Plucińska, K., Glac, W., & Wrona, D. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.12.004 · Cited by 4
Differential Effects of Dietary Oils on Emotional and Cognitive Behaviors
Kato, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120753 · Cited by 4
Purinergic P2X Receptors as Therapeutic Targets
Stokes, L., Bidula, S. M., & Sluyter, R. (2024) · Springer eBooks · doi:10.1007/978-3-031-52197-3_13 · Cited by 2
Emerging Microglial Therapies and Targets in Clinical Trial
Yan, L., & Crotti, A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_35 · Cited by 2
The Role of Immune Cells in the Brain during Physiological and Pathological Conditions
Franklin, T., Wohleb, E. S., & Duman, R. S. (2015) · Psychiatric Annals · doi:10.3928/00485713-20150501-05 · Cited by 2
Raddatz, M. C., Newson, C. M., Stott, M., Campbell, C., & Bobeck, E. N. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115618 · Cited by 1
Resilience as a Measure of Outcome and Recovery in Schizophrenia
Dikshit, R., Lodha, P., Shrivastava, A., & Sousa, A. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-19847-3_12 · Cited by 1
Domingos, L. B. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2020.tde-19082020-223048 · Cited by 1
Pereira, V. S. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2015.tde-07072015-084140
Metadata
- Authors
- Boucher, A. A., Arnold, J. C., Hunt, G. E., Spiro, A., Spencer, J., Brown, C., McGregor, I. S., Bennett, M. R., & Kassiou, M.
- Affiliations
- The University of Sydney (AU)
- Corresponding author
- Kassiou, M.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 189
- Pages
- 170-177
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W1998622794
- Cited by
- 108
- References
- 46
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 5 · 2022: 9 · 2021: 4 · 2020: 9 · 2019: 9 · 2018: 12 · 2017: 11 · 2016: 5 · 2015: 10 · 2014: 10 · 2013: 4 · 2012: 7
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NHMRC
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- P2X7 receptor, P2X7 knockout mice, depression, resilience, repeated stress, forced swim test, Fos expression, dentate gyrus, basolateral amygdala, anxiety-like behavior, locomotor activity, major depressive disorder, bipolar disorder, P2X7 antagonists
- MeSH terms
- Animals, Anxiety, Depression, Female, Motor Activity, Stress, Psychological, Proto-Oncogene Proteins c-fos, Mice, Knockout, Maze Learning, Mice, Receptors, Purinergic P2X7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review